Skip to main content

Ciphergen to Sell Chromatography Business to Pall in $32M Deal

NEW YORK , Oct. 28 (GenomeWeb News) - Ciphergen Biosystems will sell its BioSepra process chromatography business to Pall Corporation for $32 million, and the companies will enter into a collaboration the firms said today.


New York-based Pall will establish process proteomics service centers to offer protein purification using Ciphergen's BioSepra's chromatography products and ProteinChip technology.


Ciphergen will retain certain limited rights to access BioSepra's chromatography sorbent technology for use in research and diagnostic markets, the company said.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.